Reinventing precision medicine: from dogs to humans
January 26, 2023
Presentation Detail
Speaker: Sungwon Lim, PhD, CEO & Co-Founder of ImpriMed, Inc.
Date: January 26, 20223
Description: ImpriMed provides an anticancer drug efficacy prediction service using artificial intelligence on a patient's live cancer cell data, aiming to help oncologists personalize a treatment regimen tailored to each patient's unique cancer in both human and veterinary oncology. ImpriMed's comparative oncology platform enables new precision medicine services for both human and animal cancers.
Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions
Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model